| All Releases |
|---|
 |
Volcano Corporation Presentation at Roth Capital Partners Conference to be Webcast
Mar 9, 2010
|
19.4 KB
|
| |
SAN DIEGO, March 9, 2010 /PRNewswire via COMTEX News Network/ -- Volcano Corporation (Nasdaq: VOLC), a leading developer and manufacturer of precision intravascular therapy guidance tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, said today that it will be participating in the 22nd Annual Roth OC G...
|
|
|
Volcano Reports 44 Percent Increase in Fourth Quarter Revenues
Mar 3, 2010
|
35.5 KB
|
| |
SAN DIEGO, March 3, 2010 /PRNewswire via COMTEX News Network/ -- Volcano Corporation (Nasdaq: VOLC), a leading developer and manufacturer of precision intravascular therapy guidance tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, said today that revenues for the quarter ended December 31, 2009, wer...
|
|
|
Volcano Corporation Schedules Fourth Quarter Conference Call, Webcast
Feb 24, 2010
|
19.4 KB
|
| |
SAN DIEGO, Feb 24, 2010 /PRNewswire via COMTEX News Network/ -- Volcano Corporation (Nasdaq: VOLC), a leading developer and manufacturer of precision intravascular therapy guidance tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, today announced that it will report its operating results for the fou...
|
|
|
Volcano Receives FDA Clearance to Market the Eagle Eye(R) Platinum Digital IVUS Catheter
Feb 9, 2010
|
22.3 KB
|
| |
SAN DIEGO, Feb 09, 2010 /PRNewswire via COMTEX News Network/ -- Volcano Corporation (Nasdaq: VOLC), a leading developer and manufacturer of precision intravascular therapy guidance tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, announced today that it has received 510(k) clearance from the U.S. F...
|
|
|
Volcano Corporation Completes Acquisition of Lumen Biomedical's Xtract(TM) Thrombus Aspiration Catheter
Feb 9, 2010
|
23.6 KB
|
| |
SAN DIEGO, Feb 09, 2010 /PRNewswire via COMTEX News Network/ -- Volcano Corporation (Nasdaq: VOLC), a leading developer and manufacturer of precision intravascular therapy guidance tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, announced today that it has acquired the Xtract(TM) Thrombus Aspirati...
|
|
|
Volcano Corporation Announces Litigation Status
Feb 5, 2010
|
19.6 KB
|
| |
SAN DIEGO, Feb 05, 2010 /PRNewswire via COMTEX News Network/ -- Volcano Corporation (Nasdaq: VOLC) today announced that the jury in the litigation filed by Lightlab Imaging, Inc. on January 7, 2009 in the Superior Court of Massachusetts, Suffolk County reached a verdict against Volcano and its wholly owned subsidiary, Axsun Technologies. In Decem...
|
|
|
Volcano Corporation Announces Preliminary Record Revenues for Fourth Quarter 2009; Total Year Revenues are Expected to Exceed Prior Guidance
Jan 11, 2010
|
22.0 KB
|
| |
SAN DIEGO, Jan 11, 2010 /PRNewswire via COMTEX News Network/ -- Volcano Corporation (Nasdaq: VOLC), a leader in the development, manufacture and sales of products for the diagnosis and treatment of coronary and peripheral artery disease, said today that it expects total revenues for fiscal 2009 will be approximately $228.0 million, with revenues i...
|
|
|
Volcano Corporation Presentation at J.P. Morgan Conference to be Webcast
Jan 5, 2010
|
19.8 KB
|
| |
SAN DIEGO, Jan 05, 2010 /PRNewswire-FirstCall via COMTEX News Network/ -- Volcano Corporation (Nasdaq: VOLC) a leader in the development, manufacture and sales of products for the diagnosis and treatment of coronary and peripheral artery disease, said today that it will be participating in the 28th Annual J.P. Morgan Healthcare Conference on Tuesda...
|
|
|
Volcano Corporation Announces Receipt of CE Mark for Its OCT Imaging System and Catheter
Jan 5, 2010
|
22.8 KB
|
| |
SAN DIEGO, Jan 05, 2010 /PRNewswire-FirstCall via COMTEX News Network/ -- Volcano Corporation (Nasdaq: VOLC), a leader in the development, manufacture and sales of products for the diagnosis and treatment of coronary and peripheral artery disease, announced today receipt of CE mark for their OCT (Optical Coherence Tomography) imaging system and cat...
|
|
|
Volcano Corporation Commends the Elevation of FFR to Level of Evidence A in New PCI Guidelines
Dec 22, 2009
|
24.5 KB
|
| |
SAN DIEGO, Dec 22, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Volcano Corporation (Nasdaq: VOLC), a leader in the development, manufacturing and sales of products for the diagnosis and treatment of coronary and peripheral artery disease, reacted positively to the new guidelines for treating coronary disease and heart attacks using percu...
|
|
|
Volcano Announces Installed Base Growth Milestone
Dec 15, 2009
|
24.7 KB
|
| |
SAN DIEGO, Dec 15, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Volcano Corporation (Nasdaq: VOLC), a leading developer of precision intravascular therapy guidance tools - including Fractional Flow Reserve (FFR), Intravascular Ultrasound (IVUS), Forward Looking IVUS and Optical Coherence Tomography (OCT) - designed to enhance the diagnosi...
|
|
|
Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging
Dec 4, 2009
|
24.9 KB
|
| |
BILLERICA, Mass., Dec 04, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Axsun Technologies, Inc., a wholly-owned subsidiary of Volcano Corporation (Nasdaq: VOLC), today announced the initial development and successful testing of a novel integrated light source architecture for OCT imaging. Axsun believes this proprietary optical engine de...
|
|
|
Volcano Corporation Presentation at Piper Jaffray Conference to be Webcast
Nov 24, 2009
|
20.2 KB
|
| |
SAN DIEGO, Nov 24, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Volcano Corporation (Nasdaq: VOLC), a leader in the development, manufacture and sales of products for the diagnosis and treatment of coronary and peripheral artery disease, said today that it will be participating in the 21st Annual Piper Jaffray Health Care Conference on Tu...
|
|
|
Volcano Corporation Presentation at Canaccord Adams Conference to Be Webcast
Nov 9, 2009
|
20.2 KB
|
| |
SAN DIEGO, Nov 09, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Volcano Corporation (Nasdaq: VOLC), a leader in the development, manufacture and sales of products for the diagnosis and treatment of coronary and peripheral artery disease, said today that it will be participating in the Third Annual Canaccord Cardiovascular Conference on Tu...
|
|
|
Volcano Reports 22 Percent Increase in Third Quarter Revenues
Nov 5, 2009
|
36.1 KB
|
| |
SAN DIEGO, Nov 05, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Volcano Corporation (Nasdaq: VOLC), a leader in the development, manufacture and sales of products for the diagnosis and treatment of coronary and peripheral artery disease, today reported revenues of $53.9 million for the third quarter of fiscal 2009.
The results for the qu...
|
|
|
Volcano Corporation Schedules Third Quarter Conference Call, Webcast
Oct 26, 2009
|
19.9 KB
|
| |
SAN DIEGO, Oct 26, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Volcano Corporation (Nasdaq: VOLC), a leader in the development, manufacture and sales of products for the diagnosis and treatment of coronary and peripheral artery disease, today announced that it will report its operating results for the third quarter and first nine months ...
|
|
|
Volcano Corporation Presentation at BIOCOM Investor Conference to Be Webcast
Oct 21, 2009
|
20.2 KB
|
| |
SAN DIEGO, Oct 21, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Volcano Corporation (Nasdaq: VOLC), a leader in the development, manufacture and sales of products for the diagnosis and treatment of coronary and peripheral artery disease, said today that it will be participating in the BIOCOM Investor Conference on Monday, October 26.
The...
|
|
|
Results From Landmark PROSPECT Trial Demonstrate the Ability of Volcano's VH(R) IVUS Imaging to Identify Plaques Most Likely to Cause Heart Attacks
Sep 24, 2009
|
26.6 KB
|
| |
SAN FRANCISCO, Sept 24, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Volcano Corporation (Nasdaq: VOLC), a leader in the development, manufacturing and sales of products for the diagnosis and treatment of coronary and peripheral artery disease, announced today imaging results from PROSPECT, the landmark 700 patient natural history study s...
|
|
|
Volcano Corporation Praises FAME Study Results
Sep 23, 2009
|
23.5 KB
|
| |
SAN FRANCISCO, Sept 23, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Volcano Corporation (Nasdaq: VOLC), a leader in the development, manufacturing and sales of products for the diagnosis and treatment of coronary and peripheral artery disease, said today that the two-year results of the Fractional Flow Reserve (FFR) vs. Angiography for M...
|
|
|
Volcano Corporation Announces Schedule of Events for the 2009 Transcatheter Cardiovascular Therapeutics (TCT) Conference
Sep 21, 2009
|
25.5 KB
|
| |
SAN FRANCISCO, Sept 21, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Volcano Corporation (Nasdaq: VOLC), a leader in the development, manufacturing and sales of products for the diagnosis and treatment of coronary and peripheral artery disease, announced today its participation in the 2009 Transcatheter Cardiovascular Therapeutics (TCT) c...
|
|
|
